Neurology
- DISEASE INDICATIONS: Amyotrophic Lateral Sclerosis (ALS), Cerebral Infarction
- MANUFACTURER: Daiichi Sankyo Company Limited
- USAGE: Intravenous
- MEDICINE APPROVED BY:
- Pharmaceuticals and Medical Devices Agency (PMDA)
Edaravone, marketed under the brand name Radicava, is a medication developed by Daiichi Sankyo that is used to treat amyotrophic lateral sclerosis (ALS), a progressive and incurable neurological disease that affects nerve cells in the brain and spinal cord.
Read more